CYP3A4*1B but Not CYP3A5*3 as Determinant of Long-Term Tacrolimus Dose Requirements in Spanish Solid Organ Transplant Patients.

Authors: Concha, Julia¹ (AUTHOR) jconcha@usj.es, Sangüesa, Estela¹ (AUTHOR), Ribate, María Pilar¹ (AUTHOR) mpribate@usj.es, García, Cristina B.¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11327. 12p.

Subject Terms: *SINGLE nucleotide polymorphisms, *LINKAGE disequilibrium, *CYTOCHROME P-450 CYP3A, *TACROLIMUS, *IMMUNOSUPPRESSIVE agents

Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine

Authors: Sangüesa, Estela, Cirujeda, Christine, Concha, Julia, Padilla, Pedro Pablo, García, Cristina Belén, Ribate, María Pilar

Source: Personalized medicine. 19(3):181-192

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187943793.0x000001&indx=1&recIds=ETOCvdc_100187943793.0x000001

Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?

Authors: Sangüesa, Estela, Cirujeda, Christine, Concha, Julia, Padilla, Pedro Pablo, García, Cristina Belén, Ribate, María Pilar

Source: In Chemico-Biological Interactions 1 September 2022 364

Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient.

Authors: Concha, Julia¹ (AUTHOR) jconcha@usj.es, Sangüesa, Estela¹ (AUTHOR), Saez-Benito, Ana M.¹ (AUTHOR), Aznar, Ignacio¹ (AUTHOR), Berenguer, Nuria¹ (AUTHOR), Saez-Benito, Loreto¹ (AUTHOR), Ribate, M. Pilar¹ (AUTHOR) mpribate@usj.es, García, Cristina B.¹ (AUTHOR)

Source: Life (2075-1729). Aug2023, Vol. 13 Issue 8, p1627. 14p.

Subject Terms: *P-glycoprotein, *DRUG interactions, *PHARMACOGENOMICS, *KIDNEY transplantation, *PREGNANE X receptor

Has the Toxicity of Therapeutic Deep Eutectic Systems Been Assessed?

Authors: García, Cristina B.¹, cbgarcia@usj.es, Concha, Julia¹, Culleré, Laura¹, Lomba, Laura¹, Sangüesa, Estela¹, esanguesa@usj.es, Ribate, Mª Pilar¹

Source: Applied Sciences (2076-3417); May2023, Vol. 13 Issue 10, p5980, 17p

Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report

Authors: Sangüesa, Estela, Cirujeda, Christine, Concha, Julia, Padilla, Pedro Pablo, Ribate, María Pilar, García, Cristina Belén

Source: Pharmacogenomics. 20(12):871-877

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186574403.0x000001&indx=1&recIds=ETOCvdc_100186574403.0x000001

Deep Eutectic Solvents: Are They Safe?

Authors: Lomba, Laura¹, mpribate@usj.esllomba@usj.es, Ribate, Mª Pilar¹, Sangüesa, Estela¹, Concha, Julia¹, Garralaga, M ª Pilar¹, Errazquin, Diego¹, García, Cristina B.¹, Giner, Beatriz¹

Source: Applied Sciences (2076-3417); Nov2021, Vol. 11 Issue 21, p10061, 21p

Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia.

Authors: Sangüesa, Estela, Fernández-Egea, Emilio, Concha, Julia, García, Cristina B., Ribate, María Pilar

Source: Biomedicines; Mar2024, Vol. 12 Issue 3, p597, 11p

Subject Terms: CLOZAPINE, PEOPLE with schizophrenia, TREATMENT effectiveness, INDIVIDUALIZED medicine, PATIENT monitoring

Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus

Authors: Concha, Julia, Sangüesa, Estela, Peña, Jose Luis, Ribate, María Pilar, García, Cristina Belén

Source: Pharmacogenomics; October 2023, Vol. 24 Issue: 15 p797-808, 12p

Pharmacogenetic studies: a tool to improve antidepressant therapy.

Authors: Ramos, Marta, Berrogain, Cecilia, Concha, Julia, Lomba, Laura, García, Cristina Belén, Ribate, Ma Pilar

Source: Drug Metabolism & Personalized Therapy; Dec2016, Vol. 31 Issue 4, p197-204, 8p